What We've Been Reading About Coordinated Digital Therapy Programs

Two companies in the chronic musculoskeletal pain space have published peer-reviewed outcomes from coordinated, therapy-first digital programs.

While we've been building 76 Health, we've spent time reading what their data actually shows.

Both companies — Hinge Health and Sword Health — have models that combine remote physical therapy, behavioral support, outcome tracking, and care coordination for patients with chronic back, neck, joint, and other musculoskeletal pain. The patient populations and study designs aren't identical to what we're building. But the published findings tell us something useful about what happens when coordinated, therapy-first care is delivered at scale.

Here's what we've taken from the research, and what we think it does and doesn't mean.

The Hinge Health JMIR 2022 outcomes

The Hinge Health evaluation published in the Journal of Medical Internet Research in 2022 looked at patients enrolled in their coordinated digital therapy-first program for chronic back, neck, and joint pain.

Two findings get cited most often.

First, a roughly 68 percent reduction in pain among participants who engaged with the program.

Second, a roughly 67 percent reduction in surgical intent — meaning patients who had been considering surgery were less likely to be considering it after the program.

Both numbers are striking. Both deserve context.

The pain reduction is averaged across a population that completed the program — selection effects matter. Patients who weren't getting value tended to disengage, which shapes the denominator. The surgical intent reduction is self-reported, not an actual reduction in procedures performed (although other studies have shown coordinated therapy-first programs do reduce procedure rates, just not as cleanly).

But even with appropriate caveats, the direction is clear. A coordinated, therapy-first program for chronic musculoskeletal pain produces meaningful reductions in both symptoms and downstream escalation, at scale, in real-world conditions.

The Sword Health published outcomes

Sword Health has published multiple peer-reviewed outcomes from their digital musculoskeletal care program. A few findings consistently emerge.

Pain reductions in the 50 to 60 percent range across enrolled populations.

A roughly 53 percent reduction in opioid use among patients in coordinated programs for chronic musculoskeletal pain.

Significant improvements in functional measures, not just symptom severity.

The opioid use reduction is the one we keep coming back to. The opioid crisis has changed how prescribers think about chronic pain medication, but it hasn't changed the underlying pressure to do something for pain that doesn't resolve. A program that produces meaningful opioid reduction without leaving patients in worse pain is doing real work.

What the data is and isn't telling us

The Hinge and Sword findings aren't proof of one company's particular approach. They're evidence that coordinated, therapy-first care, when delivered with infrastructure and rigor, produces results that fragmented care typically doesn't.

There are a few specific things we take from the data.

The pain reduction findings tell us that movement-based therapy, when delivered consistently and supported by behavioral and coordination infrastructure, produces meaningful symptom improvement at population scale.

The surgical intent and opioid reduction findings tell us that the escalation patterns that drive cost and harm in chronic pain care are not inevitable. They respond to whether or not patients have access to coordinated alternatives.

The retention and engagement data — less often discussed but present in the studies — tells us that infrastructure matters. The patients who get the benefit aren't the ones who try the program once. They're the ones who stay engaged across the arc of treatment. What keeps them engaged is the coordination layer, not the therapy itself.

What this doesn't mean

These findings shouldn't be read as outcomes we expect our patients to achieve.

We haven't published our outcomes. We don't have enough patients yet to publish anything meaningful. The literature describes what other coordinated therapy-first programs have done — and it informs how we're building. It doesn't predict what we'll deliver.

The model populations Hinge and Sword studied aren't identical to the patients we'll work with. The interventions aren't identical. The infrastructure isn't identical. Apply the findings to our patients the way you'd apply any external evidence — as informative, not predictive.

What the literature does tell us is that the structural choice to coordinate care, lead with therapy, and stay with patients across the arc has been shown to work, at scale, with peer-reviewed evidence.

That's part of what gives us the confidence to keep building.

What we've been thinking about

The published outcomes from Hinge and Sword shape how we think about our own infrastructure — but they also shape how we talk about what we're doing.

We're careful not to claim their outcomes as ours. We cite their findings as evidence that coordinated therapy-first care is a real and studied approach, and that the model we're building has the published literature behind it as a category.

Our own outcomes will come from our own patients, our own infrastructure, and our own design choices. When we have enough data to publish them, we will.

In the meantime, the research from these programs is part of how we anchor our own thinking. The principle isn't that any specific program is the model to copy. The principle is that coordinated, therapy-first care has been shown to work — and that the work of building it well is worth doing.

Sources: Hinge Health peer-reviewed published outcomes in the Journal of Medical Internet Research (2022); Sword Health peer-reviewed published outcomes (multiple studies).